ST-503 will be evaluated in a phase 1/2 trial with the first patient scheduled to receive the therapy in the coming months. The Food and Drug Administration (FDA) has granted Fast Track designation to ...

Please provide your email address to receive an email when new articles are posted on . The FDA has cleared an investigational new drug application for an epigenetic regulator to treat intractable ...

Sangamo Therapeutics Inc. has received IND clearance from the FDA for ST-503, an investigational epigenetic regulator for the treatment of intractable pain due to idiopathic small fiber neuropathy ...

Neuropathy, the nerve damage that causes pain and numbness in the feet and hands and can eventually lead to falls, infection and even amputation, is very common and underdiagnosed, according to a ...

Peripheral neuropathy, in its simplest definition, is damage to the peripheral nerves located outside the brain and spinal cord. It is a relatively common condition that is not isolated to any ...

Peripheral neuropathy pain can be excruciating and life-altering. What many patients don’t realize is that their mysterious nerve pain may actually be connected to an underlying Lyme disease infection ...

This story was produced by April D. Lee and distributed by Next Net. Healthy nerves are necessary for movement, sensation, and overall quality of life. Damaged nerves, on the other hand, can have ...

In a new study published in The Journal of Clinical Investigation, Eroboghene Ubogu, M.D., professor in the University of Alabama at Birmingham Department of Neurology and director of the Division of ...